| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.14 | 0.4 |